Bull
$2.58
Scenario price
$2.340
-0.087 (-3.70%)At close
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Helius Medical Technologies Inc (HSDT) is a good buy right now, trading at $2.34 with a recent RSI of 71.625 indicating strong momentum. The stock has shown a significant 41.82% increase over the past 20 days, suggesting positive short-term performance. Additionally, analysts project a price target of $3 to $4, indicating potential upside of 28.0% to 70.6%. However, the main risk is the company's negative earnings with a forward P/E of 0 and a recent quarterly loss of $0.05 per share, which could affect investor sentiment.
B. Riley
$3
2026-04-23
B. Riley
2026-04-23
Price Target
$3
Maxim Group
—
2024-10-16
Maxim Group
2024-10-16
Price Target
—
Roth MKM
$24
2024-03-05
Roth MKM
2024-03-05
Price Target
$24
Maxim Group
$50
2022-12-20
Maxim Group
2022-12-20
Price Target
$50
Roth Capital
$250
2022-08-23
Roth Capital
2022-08-23
Price Target
$250
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Solana Company Announces Governance Voting Positions Ahead of SGPs

Solana Co Reports Q2 2026 Earnings with Mixed Results

Solana Company Reports Larger Than Expected Quarterly Loss

Solana Company Signs Blockchain Partnership MoU with Alatau City

Solana Board Rejects Acquisition Proposal, Prioritizes Shareholder Interests
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
Helius Medical Technologies Inc (HSDT) is a good buy right now, trading at $2.34 with a recent RSI of 71.625 indicating strong momentum. The stock has shown a significant 41.82% increase over the past 20 days, suggesting positive short-term performance. Additionally, analysts project a price target of $3 to $4, indicating potential upside of 28.0% to 70.6%. However, the main risk is the company's negative earnings with a forward P/E of 0 and a recent quarterly loss of $0.05 per share, which could affect investor sentiment.
1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.